Daniela Cocconi

This inventor holds 9 USPTO granted patents and 10 published patent applications, plus 6 CIPO patents and 13 EPO patents. Top assignee: Chiesi Farmaceutici S.p.a.. Active years: 2012-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Daniela Cocconi. Retrieved from https://idiyas.com/inventor/daniela-cocconi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 9 (Patent Applications = 10)

% Patents Active = 100.0

CIPO Patents = 6

EPO Patents = 13 (Patent Applications = 16)

Average Co-Inventor Count = 3.7

ph-index = 3

Forward Citations = 28(Granted Patents)

Company Filing History:

9 out of 342

Chiesi Farmaceutici S.p.a.

patents

Years Active: 2012-2021

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10946029 - Dry powder formulation comprising a corticosteroid and a beta-adrenergic for administration by inhalation (2021-03-16),

2. 10028964 - Dry powder formulation comprising a corticosteroid and a beta-adrenergic for administration by inhalation (2018-07-24),

3. 9445999 - Process for preparing carrier particles for dry powders for inhalation (2016-09-20),

4. 9308200 - Dry powder formulation comprising a phosphodiesterase inhibitor (2016-04-12),

5. 9132121 - Dry powder formulation comprising a phosphodiesterase inhibitor (2015-09-15),

6. 8974831 - Process for preparing carrier particles for dry powders for inhalation (2015-03-10),

7. 8778402 - Dry powder formulation comprising a corticosteroid and a beta-adrenergic for administration by inhalation (2014-07-15),

8. 8512753 - Micronized particles of low-dosage strength active agents for powder formulations for inhalation (2013-08-20),

9. 8153104 - Pharmaceutical formulations for dry powder inhalers comprising a low-dosage strength active ingredient (2012-04-10),

Title: Daniela Cocconi: Innovator in Pharmaceutical Formulations

Introduction

Daniela Cocconi is a prominent inventor based in Parma, Italy. She has made significant contributions to the field of pharmaceutical formulations, particularly in the development of dry powder formulations for inhalation therapies. With a total of 9 patents to her name, Cocconi's work has had a substantial impact on the treatment of respiratory diseases.

Latest Patents

Among her latest patents, Cocconi has developed a dry powder formulation comprising a corticosteroid and a beta-adrenergic for administration by inhalation. This formulation is particularly useful for treating inflammatory or obstructive airway diseases. Another notable patent involves a similar dry powder formulation that includes a corticosteroid and a beta-adrenergic drug in combination, detailing its preparation process and therapeutic uses.

Career Highlights

Cocconi is currently associated with Chiesi Farmaceutici S.p.A., a leading pharmaceutical company known for its innovative approaches to respiratory therapies. Her work at Chiesi has allowed her to focus on developing effective treatments that improve patient outcomes in respiratory health.

Collaborations

Throughout her career, Cocconi has collaborated with talented professionals, including Elisa Monari and Anna Maria Cantarelli. These collaborations have fostered a creative environment that enhances the development of innovative pharmaceutical solutions.

Conclusion

Daniela Cocconi's contributions to the field of pharmaceutical formulations exemplify her dedication to improving respiratory health through innovation. Her patents and collaborations reflect her commitment to advancing medical science and enhancing patient care.

Profile summary based on public USPTO records.